☰

Rory Curtis

Affiliations: 
Elixir Pharmaceuticals, Cambridge, MA, United States 
Area:
GAP43, glia, ion channels, regeneration, neurotrophins, GAP-43
Google:
"Rory Curtis"
Bio:

Email: rorycurtis@comcast.net ............ History: PhD, Biochemistry, Imperial College, London, UK;
Post-doc, Regeneron Pharmaceuticals, NY;
Lecturer, Bristol University, Bristol, UK;
Senior Scientist, Millennium Pharmaceuticals, MA;
Senior Director, Elixir Pharmaceuticals, MA;

Mean distance: 14.95 (cluster 11)
 		SNBCP
Cross-listing: Chemistry Tree

Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Michael R. Hanley research assistant 1985-1987 Imperial College London
Graham P. Wilkin grad student 1985-1991 Imperial College London
Peter S. DiStefano post-doc 1991-1995 Regeneron Pharmaceuticals
Ronald M. Lindsay post-doc 1991-1995 Regeneron Pharmaceuticals

Children

Sign in to add trainee
Scott Eliasof research scientist 2000-2001 Millennium Pharmaceuticals
Tara M. D'Eon research scientist 2006-2007 Elixir Pharmaceuticals
Julie Huber research scientist 2002-2008 Elixir Pharmaceuticals

Collaborators

Sign in to add collaborator
William A. Catterall collaborator Wahington University
David E. Clapham collaborator Harvard Medical School/HHMI
Susan M. Hall collaborator Guy's Hospital, London
Mats H. Holmqvist collaborator Millennium Pharmaceuticals
Krisjan Jessen collaborator UCL
Irwin Levitan collaborator Boston University, Brandeis University
Rhona Mirsky collaborator UCL
John V. Priestley collaborator Thomas's Hospital, London
Steven S. Scherer collaborator Penn
Immaculada Silos-Santiago collaborator Millennium Pharmaceuticals
Barbara A. Spruce collaborator Imperial College, London
Helen Stewart collaborator UCL
Carlos Ibanez collaborator 1993-1995 Regeneron Pharmaceuticals
David Wynick collaborator 1995-1997 University of Bristol
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Longo KA, Govek EK, Nolan A, et al. (2012) Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivity (Journal of Pharmacology and Experimental Therapeutics (2011) 339, (115-124)) Journal of Pharmacology and Experimental Therapeutics. 340: 810
Longo KA, Govek EK, Nolan A, et al. (2011) Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivity. The Journal of Pharmacology and Experimental Therapeutics. 339: 115-24
DiStefano PS, Curtis R, Geddes BJ. (2007) Insulin resistance, glycemic control and adiposity: key determinants of healthy lifespan. Current Alzheimer Research. 4: 153-7
Curtis R, O'Connor G, DiStefano PS. (2006) Aging networks in Caenorhabditis elegans: AMP-activated protein kinase (aak-2) links multiple aging and metabolism pathways. Aging Cell. 5: 119-26
Solomon JM, Pasupuleti R, Xu L, et al. (2006) Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Molecular and Cellular Biology. 26: 28-38
Napper AD, Hixon J, McDonagh T, et al. (2005) Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. Journal of Medicinal Chemistry. 48: 8045-54
McDonagh T, Hixon J, DiStefano PS, et al. (2005) Microplate filtration assay for nicotinamide release from NAD using a boronic acid resin. Methods (San Diego, Calif.). 36: 346-50
Curtis R, Geesaman BJ, DiStefano PS. (2005) Ageing and metabolism: drug discovery opportunities. Nature Reviews. Drug Discovery. 4: 569-80
Kaeberlein M, McDonagh T, Heltweg B, et al. (2005) Substrate-specific activation of sirtuins by resveratrol. The Journal of Biological Chemistry. 280: 17038-45
Apfeld J, O'Connor G, McDonagh T, et al. (2004) The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes & Development. 18: 3004-9
See more...